Nutreco has announced an investment in Israeli startup ViAqua as part of its focus on combatting disease in the aquaculture industry. ViAqua is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics.
Already subscribed? SIGN IN now
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:
Get more free content sign up today
Ready to subscribe? Choose from one of our subscription packages for unlimited access!